Rhumbline Advisers 908 Devices Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in 908 Devices Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 36,416 shares of MASS stock, worth $324,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,416
Previous 34,522
5.49%
Holding current value
$324,466
Previous $154,000
68.18%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MASS
# of Institutions
106Shares Held
24.4MCall Options Held
39KPut Options Held
11.9K-
Awm Investment Company, Inc. New York, NY5.2MShares$46.3 Million5.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.65MShares$23.6 Million0.16% of portfolio
-
State Street Corp Boston, MA2.29MShares$20.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$12.8 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $281M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...